Rocket Pharmaceuticals, Inc.RCKTNASDAQ
Loading
R&D Expenses Over TimeContracting
Percentile Rank77
3Y CAGR-5.0%
5Y CAGR+5.9%
Year-over-Year Change
Research and development spending
3Y CAGR
-5.0%/yr
vs +32.8%/yr prior
5Y CAGR
+5.9%/yr
Recent deceleration
Acceleration
-37.8pp
Decelerating
Percentile
P77
Within normal range
vs 5Y Ago
1.3x
Solid growth
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $142.01M | -17.1% |
| 2024 | $171.24M | -8.1% |
| 2023 | $186.34M | +12.5% |
| 2022 | $165.57M | +32.0% |
| 2021 | $125.48M | +17.9% |
| 2020 | $106.38M | +81.5% |
| 2019 | $58.62M | +10.0% |
| 2018 | $53.27M | +275.3% |
| 2017 | $14.19M | -55.6% |
| 2016 | $31.98M | - |